HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gary D Steinberg Selected Research

Urinary Diversion (Ileal Conduit)

5/2018Perioperative and long-term outcomes after radical cystectomy in hemodialysis patients.
1/2018Fistulous Complications following Radical Cystectomy for Bladder Cancer: Analysis of a Large Modern Cohort.
1/2017Lessons from 151 ureteral reimplantations for postcystectomy ureteroenteric strictures: A single-center experience over a decade.
3/2016The effect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomy.
2/2015The effect of length of ureteral resection on benign ureterointestinal stricture rate in ileal conduit or ileal neobladder urinary diversion following radical cystectomy.
1/2015Radical Cystectomy with Ileal Conduit Urinary Diversion in a Patient with a Left Ventricular Assist Device.
10/2014Prospective health-related quality of life analysis for patients undergoing radical cystectomy and urinary diversion.
4/2014Cystectomy and urinary diversion as management of treatment-refractory benign disease: the impact of preoperative urological conditions on perioperative outcomes.
9/2013The impact of running versus interrupted anastomosis on ureterointestinal stricture rate after radical cystectomy.
11/2012The impact of mechanical bowel preparation on postoperative complications for patients undergoing cystectomy and urinary diversion.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gary D Steinberg Research Topics

Disease

33Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2008
30Neoplasms (Cancer)
02/2022 - 11/2005
16Non-Muscle Invasive Bladder Neoplasms
01/2022 - 09/2011
7Prostatic Neoplasms (Prostate Cancer)
01/2019 - 08/2003
7Pathologic Constriction (Stenosis)
01/2017 - 10/2002
6Carcinoma (Carcinomatosis)
01/2020 - 09/2014
5Hemorrhage
01/2017 - 11/2002
4Fistula
01/2018 - 11/2002
3Ileus
04/2017 - 06/2014
3Margins of Excision
01/2017 - 12/2006
3Infections
03/2016 - 10/2003
3Carcinoma in Situ
04/2015 - 05/2011
3Adenocarcinoma
08/2013 - 08/2003
2Lymphatic Metastasis
01/2020 - 01/2008
2Neoplasm Metastasis (Metastasis)
01/2020 - 12/2018
2Renal Cell Carcinoma (Grawitz Tumor)
11/2019 - 11/2002
2Wounds and Injuries (Trauma)
01/2017 - 11/2012
2Hematuria
08/2006 - 08/2003
2Flank Pain
09/2004 - 10/2003
1Residual Neoplasm
01/2022
1COVID-19
10/2021
1Tuberculosis (Tuberculoses)
10/2021
1Thrombosis (Thrombus)
11/2019
1Kidney Neoplasms (Kidney Cancer)
11/2019
1Penile Neoplasms (Penile Cancer)
12/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2018
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
05/2018
1Intestinal Obstruction (Obstruction, Intestinal)
04/2017
1Thromboembolism
01/2017
1Venous Thromboembolism
01/2017
1Contracture
09/2015
1Heart Failure
01/2015

Drug/Important Bio-Agent (IBA)

4Cisplatin (Platino)FDA LinkGeneric
01/2022 - 12/2016
3Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2018
3alvimopanFDA Link
04/2017 - 06/2014
3Prostate-Specific Antigen (Semenogelase)IBA
04/2011 - 11/2007
2Complementary DNA (cDNA)IBA
01/2021 - 08/2003
2PlatinumIBA
12/2020 - 12/2016
2NivolumabIBA
01/2020 - 11/2019
2Mitomycin (Mitomycin-C)FDA LinkGeneric
02/2019 - 10/2015
2Cadherins (E-Cadherin)IBA
09/2014 - 01/2012
2valrubicin (AD 32)FDA Link
11/2013 - 05/2011
2MetalsIBA
11/2006 - 09/2004
1Peptides (Polypeptides)IBA
02/2022
1Cancer VaccinesIBA
02/2022
1GemcitabineFDA Link
01/2022
1AntibodiesIBA
01/2022
1EpitopesIBA
11/2021
1VaccinesIBA
10/2021
1Interferon alpha-2 (Roferon-A)FDA Link
01/2021
1ClaudinsIBA
12/2020
1Phenobarbital (Luminal)FDA Link
12/2020
1linrodostatIBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1Mesylates (Mesylate)IBA
01/2020
1Sunitinib (Sutent)FDA Link
11/2019
1IpilimumabIBA
11/2019
1Fluorouracil (Carac)FDA LinkGeneric
02/2019
1Capecitabine (Xeloda)FDA Link
02/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2018
1Pregnenolone Carbonitrile (PCN)IBA
01/2017
1Heparin (Liquaemin)FDA LinkGeneric
01/2017
1Enoxaparin (Lovenox)FDA LinkGeneric
01/2017
11- (2- chloroethyl)- 3- (2,6- dioxo- 3- piperidinyl)- 1- nitrosoureaIBA
01/2017
1Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric
03/2016
1Nucleic AcidsIBA
02/2016
1OzoneIBA
02/2016
1Photosensitizing Agents (Photosensitizers)IBA
10/2014
15-aminolevulinic acid hexyl esterFDA Link
10/2014
1Keratins (Keratin)IBA
09/2014
1Caspase 3 (Caspase-3)IBA
09/2014

Therapy/Procedure

42Cystectomy
01/2022 - 10/2002
20Therapeutics
02/2022 - 01/2010
17Urinary Diversion (Ileal Conduit)
05/2018 - 10/2002
9Radiotherapy
02/2019 - 10/2005
8Immunotherapy
02/2022 - 01/2013
7Drug Therapy (Chemotherapy)
12/2020 - 03/2009
7Prostatectomy (Retropubic Prostatectomy)
01/2019 - 10/2005
6Length of Stay
04/2017 - 11/2009
5Transurethral Resection of Bladder
01/2022 - 06/2014
5Nephrectomy
06/2008 - 11/2002
4Neoadjuvant Therapy
01/2022 - 05/2009
3Operative Time
12/2011 - 07/2007
3Stents
11/2006 - 10/2003
2Lymph Node Excision (Lymph Node Dissection)
12/2018 - 01/2017
2Total Parenteral Nutrition
03/2016 - 06/2014
2Minimally Invasive Surgical Procedures
11/2009 - 06/2007
2Nephrotomy
09/2004 - 10/2003
1Combination Drug Therapy (Combination Chemotherapy)
01/2022
1Salvage Therapy
01/2021
1Aftercare (After-Treatment)
01/2020
1Chemoradiotherapy
02/2019
1Renal Dialysis (Hemodialysis)
05/2018
1Replantation
01/2017
1Blood Transfusion (Blood Transfusions)
01/2017
1Nephroureterectomy
01/2017
1Cardiopulmonary Bypass (Heart-Lung Bypass)
03/2016
1Sternotomy
03/2016
1Conservative Treatment
10/2015
1Heart-Assist Devices
01/2015